Modulation of TMPRSS6 expression
US9885047B2 · kind B2 · utility
1Cited by
0References
33Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 3, 2016 |
| Grant date | Feb 6, 2018 |
| Priority date | — |
| Expiry date | Nov 3, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/346
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are antisense compounds and methods for modulating TMPRSS6 and modulating an iron accumulation disease, disorder and/or condition in an individual in need thereof. Iron accumulation diseases in an individual such as hemochromatosis or β-thalassemia can be ameliorated or prevented with the administration of antisense compounds targeted to TMPRSS6.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.